Publications by authors named "Anna Maria Repice"

Claim this Profile
A
Autologous haematopoietic stem cell transplantation affects long-term progression independent of relapse activity in aggressive multiple sclerosis: a comparative matched study.
Alice Mariottini, Anna Chiara Mazzeo, Edoardo Simonetti, Riccardo Boncompagni, Jessica Covicchio, Anna Maria Repice

J Neurol Neurosurg Psychiatry· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymic hyperplasia after autologous hematopoietic stem cell transplantation in multiple sclerosis: a case series.
Alice Mariottini, Riccardo Boncompagni, Diletta Cozzi, Edoardo Simonetti, Anna Maria Repice

Front Immunol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis.
Alice Mariottini, Emily H Stack, Govind Nair, Chiara Nozzoli, Tianxia Wu, Anna Maria Repice

Mult Scler Relat Disord· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis.
Alice Mariottini, Chiara Nozzoli, Ilaria Carli, Filippo Landi, Valentina Gigli, Anna Maria Repice

Neurol Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.
Elisabetta Maida, Marcello Moccia, Raffaele Palladino, Giovanna Borriello, Giuseppina Affinito, Anna Maria Repice

J Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation.
Leonardo Marchi, Alice Mariottini, Vittorio Viti, Andrea Bianchi, Chiara Nozzoli, Anna Maria Repice

Front Neurol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation.
Alice Mariottini, Antonio Lotti, Chiara Innocenti, Anna Maria Repice, Chiara Nozzoli

Eur J Neurol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience.
Andrea Bertozzi, Alice Mariottini, Leonardo Marchi, Maria Di Cristinzi, Riccardo Nistri, Anna Maria Repice

Mult Scler Relat Disord· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis.
Giacomo Boffa, Alessio Signori, Luca Massacesi, Alice Mariottini, Elvira Sbragia, Anna Maria Repice

Neurology· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The contribute of cerebrospinal fluid free light-chain assay in the diagnosis of multiple sclerosis and other neurological diseases in an Italian multicenter study.
Gaetano Bernardi, Tiziana Biagioli, Paola Malpassi, Teresa De Michele, Domizia Vecchio, Anna Maria Repice

Mult Scler· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance.
Alice Mariottini, Anna Maria Repice, Alessandro Barilaro, Luca Massacesi

Neurol Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous haematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis.
Alice Mariottini, Giovanni Bulgarini, Benedetta Forci, Chiara Innocenti, Fabrizia Mealli, Anna Maria Repice

Eur J Neurol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of disease-modifying treatments on antibody-mediated response to anti-COVID19 vaccination in people with multiple sclerosis.
Alice Mariottini, Andrea Bertozzi, Leonardo Marchi, Maria Di Cristinzi, Claudia Mechi, Anna Maria Repice

J Neurol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.
Maria Pia Sormani, Irene Schiavetti, Matilde Inglese, Luca Carmisciano, Alice Laroni, Anna Maria Repice

EBioMedicine· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis.
Roberta Amoriello, Roberta Rizzo, Alice Mariottini, Daria Bortolotti, Valentina Gentili, Anna Maria Repice

Front Neurol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: A population-based study on Tuscan residents.
Alice Mariottini, Benedetta Forci, Elisa Gualdani, Monica Romoli, Anna Maria Repice

Mult Scler Relat Disord· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis.
Alice Mariottini, Leonardo Marchi, Chiara Innocenti, Maria Di Cristinzi, Matteo Pasca, Anna Maria Repice

Front Neurol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.
Maria Pia Sormani, Matilde Inglese, Irene Schiavetti, Luca Carmisciano, Alice Laroni, Anna Maria Repice

EBioMedicine· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies.
Roberta Amoriello, Victor Greiff, Alessandra Aldinucci, Elena Bonechi, Alberto Carnasciali, Anna Maria Repice

Front Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
Giacomo Boffa, Luca Massacesi, Matilde Inglese, Alice Mariottini, Marco Capobianco, Anna Maria Repice

Neurology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis.
Alice Mariottini, Stefano Filippini, Chiara Innocenti, Benedetta Forci, Claudia Mechi, Anna Maria Repice

Mult Scler· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis.
Matteo Pasca, Benedetta Forci, Alice Mariottini, Claudia Mechi, Alessandro Barilaro, Anna Maria Repice

Mult Scler Relat Disord· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cladribine vs other drugs in MS: Merging randomized trial with real-life data.
Alessio Signori, Francesco Saccà, Roberta Lanzillo, Giorgia Teresa Maniscalco, Elisabetta Signoriello, Anna Maria Repice

Neurol Neuroimmunol Neuroinflamm· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of celiac disease in patients with multiple sclerosis in Tuscany.
Barbara Piccini, Monica Ulivelli, Maria Pia Amato, Sabina Bartalini, Mario Falcini, Anna Maria Repice

Rev Esp Enferm Dig· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet.
Matteo Pasca, Antonella Picchioni, Salvatore Mazzeo, Federica Terenzi, Elio Prestipino, Anna Maria Repice

Intractable Rare Dis Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis